Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of
.
Show all posts
Showing posts with label
Treatment of
.
Show all posts
Thursday, July 23, 2026
FDA Approves Nuzolvence (zoliflodacin) for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
›
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), announced the U.S. Food and Drug Administration (FDA) a...
Tuesday, July 21, 2026
FDA Approves Aqvesme (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
›
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for pati...
Thursday, May 21, 2026
FDA Approves Lasix ONYU (furosemide) for Treatment of Edema in Heart Failure
›
SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination Lasix ONYU (fu...
Tuesday, November 4, 2025
FDA Approves Onapgo (apomorphine hydrochloride) for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease
›
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatm...
›
Home
View web version